Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8.52x is in line with its 4-year average of -9.13x, near the high end of its 4-year range (-851.59x–-4.59x).
26.47% below its 12-month average of -6.74x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): -7.86x.
INTEREST COVERAGE RATIO
-8.52x
INTEREST COVERAGE RATIO AVG TTM
-6.74x
INTEREST COVERAGE RATIO AVG 3Y
-9.13x
INTEREST COVERAGE RATIO AVG 5Y
-9.13x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-26.47%
CURRENT VS 3Y AVG
+6.71%
CURRENT VS 5Y AVG
+6.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-33.65%
vs the sector median at left
Optimi Health Corp.
Market Cap
$13.48M
Interest Coverage Ratio
-8.52x
TTM Avg
-6.74x
3Y Avg
-9.13x
5Y Avg
-9.13x
Market Cap
$13.20M
Interest Coverage Ratio
-143.87x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.75M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.86M
Interest Coverage Ratio
-206.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.11M
Interest Coverage Ratio
-38.62x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.79M
Interest Coverage Ratio
-5.45x
TTM Avg
0.92x
3Y Avg
0.92x
5Y Avg
0.92x
Market Cap
$12.78M
Interest Coverage Ratio
-1171.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Optimi Health Corp. (OPTH) | $13.48M | -8.52x | -6.74x | -9.13x | -9.13x |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -143.87x | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.33M | N/A | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | -206.17x | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.11M | -38.62x | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG)vs › | $12.69M | N/A | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.79M | -5.45x | 0.92x | 0.92x | 0.92x |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | -1171.55x | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | -18.73x | N/A | N/A | N/A |
Interest Coverage
-8.5x
Debt/Equity
0.29
Current Ratio
1.73
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -7.86x |
| 2026-03-31 | -5.73x |
| 2025-12-31 | -4.59x |
| 2025-09-30 | -8.23x |
| 2025-06-30 | -7.27x |
| 2025-03-31 | -8.87x |
| 2024-12-31 | -10.72x |
| 2024-09-30 | -11.85x |
| 2024-06-30 | -9.74x |
| 2024-03-31 | -13.56x |
| 2023-12-31 | -12.02x |
| 2023-09-30 | -41.83x |
| 2022-09-30 | -851.59x |
| 2020-12-31 | -65.89x |
